Clinical Trial Search Results for "PROTECT-TIMI 30"

Gibson, C. M., Karmpaliotis, D., Kosmidou, I., Murphy, S. A., Kirtane, A. J., Budiu, D., Ray, K. K., Herrmann, H. C., Lakkis, N., Kovach, R., French, W., Blankenship, J., Lui, H. H., Palabrica, T., Jennings, L. K., Cohen, D. J., Morrow, D. A. Comparison of effects of bare metal versus drug-eluting stent implantation on biomarker levels following percutaneous coronary intervention for non-ST-elevation acute coronary syndrome Am J Cardiol. 2006;97(10):1473-7.

Gibson, C. M., Kirtane, A. J., Morrow, D. A., Palabrica, T. M., Murphy, S. A., Stone, P. H., Scirica, B. M., Jennings, L. K., Herrmann, H. C., Cohen, D. J., McCabe, C. H., Braunwald, E. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30) Am Heart J. 2006;152(4):756-61.

Gibson, C. M., Morrow, D. A., Murphy, S. A., Palabrica, T. M., Jennings, L. K., Stone, P. H., Lui, H. H., Bulle, T., Lakkis, N., Kovach, R., Cohen, D. J., Fish, P., McCabe, C. H., Braunwald, E. A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006;47(12):2364-73.

Kirtane, A. J., Piazza, G., Murphy, S. A., Budiu, D., Morrow, D. A., Cohen, D. J., Peterson, E., Lakkis, N., Herrmann, H. C., Palabrica, T. M., Gibson, C. M. Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial J Am Coll Cardiol. 2006;47(12):2374-9.

Gibson, C. M., Pride, Y. B., Buros, J. L., Ciaglo, L. N., Morrow, D. A., Scirica, B. M., Stone, P. H. Timing and duration of myocardial ischemia on Holter monitoring following percutaneous coronary intervention and their association with clinical outcomes (a PROTECT-TIMI 30 Substudy Analysis) Am J Cardiol. 2009;104(1):36-40.

Wilson, S. R., Sabatine, M. S., Braunwald, E., Sloan, S., Murphy, S. A., Morrow, D. A. Detection of myocardial injury in patients with unstable angina using a novel nanoparticle cardiac troponin I assay: observations from the PROTECT-TIMI 30 Trial American heart journal. 2009;158(3):386-91. Abstract

Kunadian, V., Pride, Y. B., Buros, J. L., Ciaglo, L. N., Morrow, D. A., Gibson, C. M. Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: a PROTECT TIMI-30 analysis J Thromb Thrombolysis. 2011;32(4):448-52. Abstract